Repeated dose 90-day oral toxicity study of Vitex megapotamica (Spreng.) Moldenke-Reference-Cited by-同舟云学术

Repeated dose 90-day oral toxicity study of Vitex megapotamica (Spreng.) Moldenke

Published:2021-01-25 Issue: Volume: Page:1-9
ISSN:0148-0545
Container-title:Drug and Chemical Toxicology
language:en
Short-container-title:Drug and Chemical Toxicology

Author:

Ribeiro Rita de Cássia Lima¹,Donadel Guilherme¹,Ames Maria Leticia¹,Nunes Bruna¹,Dalmagro Mariana¹,Belettini Salviano Tramontin¹,Soares Andreia Assunção¹,Jacomassi Ezilda¹,Gasparotto Junior Arquimedes²,Alberton Odair¹,Lorenço Emerson Luiz Botelho¹

Affiliation:

1. Laboratory of Preclinical Research of Natural Products, Paranaense University, Umuarama, Brazil

2. Faculty of Health Sciences, Laboratory of Cardiovascular Pharmacology (LaFaC), Federal University of Grande Dourados, Dourados, Brazil

Funder

Paranaense University – UNIPAR

Fundação Araucária

PROSUP/CAPES

Arquimedes Gasparotto Junior

Emerson Luiz Lorenço Botelho

Odair Alberton

CNPq

National Council for Scientific and Technological Development

Publisher

Informa UK Limited

Subject

Chemical Health and Safety,Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health,Pharmacology,Toxicology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/01480545.2021.1878209

Reference24 articles.

1. ANVISA (Agência Nacional de Vigilância Sanitária), 2004. Resolução RDC N° 48, de 16 de março de 2004, Dispõe sobre o registro de medicamentos fitoterápicos. Diário Oficial da União; Poder Executivo, publicado no dia 18 de março de 2004. Disponível em. http://e-legis.bvs.br. [Accessed 16 Jul 2018].

2. Renoprotective Effects ofVitex megapotamica(Spreng.) Moldenke in C57BL/6 LDLr-Null Mice Undergoing High Fat Diet

3. TOTAL PHENOLIC AND FLAVONOID CONTENT AND ANTIOXIDANT ACTIVITY OF VITEX MONTEVIDENSIS (SPRENG) MOLDENKE - VERBENACEAE